Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection

被引:41
|
作者
Bartak, Barbara Kinga [1 ]
Kalmar, Alexandra [1 ]
Galamb, Orsolya [2 ]
Wichmann, Barnabas [2 ]
Nagy, Zsofia Brigitta [1 ]
Tulassay, Zsolt [1 ,2 ]
Dank, Magdolna [3 ]
Igaz, Peter [1 ,2 ]
Molnar, Bela [2 ]
机构
[1] Semmelweis Univ, Dept Internal Med 2, Szentkiralyi Str 46, H-1088 Budapest, Hungary
[2] Hungarian Acad Sci, Mol Med Res Grp, H-1088 Budapest, Hungary
[3] Semmelweis Univ, Dept Clin Oncol, H-1083 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
Liquid biopsy; Plasma; cfDNA isolation; Blood collection; Colorectal cancer; DNA methylation; FREE NUCLEIC-ACIDS; CIRCULATING DNA; PLASMA; METHYLATION; BIOMARKERS; STORAGE; MUTATION; QUALITY; ORIGIN;
D O I
10.1007/s12253-018-0382-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During colorectal cancer (CRC) development tumor-derived cell-free DNA (cfDNA) can be released into the bloodstream. Many different cfDNA isolation methods and specific blood collection tubes preventing the release of genomic DNA and stabilizing cfDNA with preservative reagents became available. These factors may affect greatly on the further liquid biopsy analyses. Our aim was to test different blood collection tubes and cfDNA isolation methods to determine whether these factors influence the cfDNA amount and the promoter methylation of four previously described hypermethylated biomarkers. Three manual isolation methods (High Pure Viral Nucleic Acid Large Volume Kit; Epi proColon 2.0 Kit; Quick-cfDNA (TM) Serum & Plasma Kit) and automated sample preparation systems (InviGenius and InviGenius PLUS) were examined. Furthermore, K3EDTA Vacuette tubes and Streck Cell-Free DNA BCT (R) tubes were compared. After cfDNA isolation and bisulfite conversion of samples, the methylation level of SFRP1, SFRP2, SDC2, and PRIMA1 were defined with MethyLight assays. We have ascertained that there are differences between the cfDNA amounts depending on the isolation methods. Higher cfDNA yield was observed using InviGenius system than column-based manual isolation method; however, InviGenius PLUS has produced lower cfDNA amounts. No remarkable variance could be found between K3EDTA and Streck tubes; slightly higher cfDNA quantity was detected in 60% of plasma samples using Streck tubes. In point of methylation level and frequency, manual column-based isolation produced more consistent results. Automated cfDNA extraction systems are easy-to-use and high-throughput; however, further improvements in the isolation protocols might lead to the increase of the sensitivity of furthermethylation analysis.
引用
收藏
页码:915 / 923
页数:9
相关论文
共 50 条
  • [21] Advancements in bladder cancer detection: a comprehensive review on liquid biopsy and cell-free DNA analysis
    Rakshit, Indraneel
    Mandal, Sudeshna
    Pal, Sreejit
    Bhattacharjee, Pritha
    NUCLEUS-INDIA, 2024,
  • [22] Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing
    Alidousty, Christina
    Brandes, Danielle
    Heydt, Carina
    Wagener, Svenja
    Wittersheim, Maike
    Schaefer, Stephan C.
    Holz, Barbara
    Merkelbach-Bruse, Sabine
    Buettner, Reinhard
    Fassunke, Jana
    Schultheis, Anne M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (05) : 801 - 804
  • [23] Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
    Palande, Vikrant
    Shay, Dorith Raviv
    Milana, Frenkel-Morgenstern
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (163): : 1 - 21
  • [24] Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients
    Schmidt, Bernd
    Reinicke, Dana
    Reindl, Iris
    Bork, Ines
    Wollschlaeger, Bettina
    Lambrecht, Nina
    Fleischhacker, Michael
    CLINICA CHIMICA ACTA, 2017, 469 : 94 - 98
  • [25] Early detection of colorectal cancer using aberrant circulating cell-free mitochondrial DNA fragmentomics
    Wang, Siyuan
    Peng, Fan
    Dang, Miao
    Jiao, Huanmin
    Zhang, Huanqin
    Zhou, Kaixiang
    Guo, Wenjie
    Gong, Zhiyun
    Guo, Lin
    Lu, Renquan
    Li, Deliang
    Liu, Bingrong
    Guo, Xu
    Xing, Jinliang
    Liu, Yang
    GUT, 2024,
  • [26] Cell-free DNA as biomarker and source for mutation detection in primary colorectal cancer
    Nikolic, Aleksandra
    Vlajnic, Marina
    Ristanovic, Momcilo
    Petrovic, Jelena
    Dimitrijevic, Ivan
    Krivokapic, Zoran
    Radojkovic, Dragica
    JOURNAL OF BUON, 2017, 22 (01): : 178 - 183
  • [27] Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
    Keup, Corinna
    Storbeck, Markus
    Hauch, Siegfried
    Hahn, Peter
    Sprenger-Haussels, Markus
    Tewes, Mitra
    Mach, Pawel
    Hoffmann, Oliver
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    CANCERS, 2019, 11 (02):
  • [28] Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol
    Sorber, Laure
    Zwaenepoel, Karen
    Jacobs, Julie
    De Winne, Koen
    Goethals, Sofie
    Reclusa, Pablo
    Van Casteren, Kaat
    Augustus, Elien
    Lardon, Filip
    Roeyen, Geert
    Peeters, Marc
    Van Meerbeeck, Jan
    Rolfo, Christian
    Pauwels, Patrick
    CANCERS, 2019, 11 (04)
  • [29] Cell-free DNA approaches for cancer early detection and interception
    Medina, Jamie E.
    Dracopoli, Nicholas C.
    Bach, Peter B.
    Lau, Anna
    Scharpf, Robert B.
    Meijer, Gerrit A.
    Andersen, Claus Lindbjerg
    Velculescu, Victor E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
  • [30] Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer
    Yu, Pengfei
    Chen, Ping
    Wu, Min
    Ding, Guangyu
    Bao, Hua
    Du, Yian
    Xu, Zhiyuan
    Yang, Litao
    Fang, Jingquan
    Huang, Xingmao
    Lai, Qian
    Wei, Jia
    Yan, Junrong
    Yang, Shanshan
    He, Peng
    Wu, Xue
    Shao, Yang
    Su, Dan
    Cheng, Xiangdong
    GENOME MEDICINE, 2024, 16 (01):